Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
2.030
0.00 (0.00%)
Sep 5, 2025, 3:00 PM CST
Kangmei Pharmaceutical Revenue
Kangmei Pharmaceutical had revenue of 1.28B CNY in the quarter ending June 30, 2025, with 0.39% growth. This brings the company's revenue in the last twelve months to 5.29B, up 6.45% year-over-year. In the year 2024, Kangmei Pharmaceutical had annual revenue of 5.19B with 6.47% growth.
Revenue (ttm)
5.29B
Revenue Growth
+6.45%
P/S Ratio
5.30
Revenue / Employee
1.25M
Employees
4,233
Market Cap
28.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.19B | 315.12M | 6.47% |
Dec 31, 2023 | 4.87B | 693.87M | 16.60% |
Dec 31, 2022 | 4.18B | 27.63M | 0.67% |
Dec 31, 2021 | 4.15B | -1.26B | -23.27% |
Dec 31, 2020 | 5.41B | -6.03B | -52.72% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |